Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Ovintiv Inc. (DE) (OVV) Price & Performance

Iovance Biotherapeutics Inc. Common StockTrade
Ovintiv Inc. (DE)Trade

Price performance (Past 24H)

Key statistics

Iovance Biotherapeutics Inc. Common Stock vs Ovintiv Inc. (DE) — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.78 (market cap $6.04B), while Ovintiv Inc. (DE) trades at $64.16 (market cap $17.53B). The key difference: Ovintiv Inc. (DE) is far larger — about 2.9× Iovance Biotherapeutics Inc. Common Stock's market cap, and Ovintiv Inc. (DE) pays a 1.89% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Ovintiv Inc. (DE) for 1 Days on average.

IOVAOVV
Market Cap
$6.04B$17.53B
Volume
14,805,9933,002,714
Sector
HealthEnergy
52-Week High
$14.82$66.97
52-Week Low
$1.81$35.97
Typical Hold Time
0 Days1 Days
Enterprise Value
$5.97B$21.86B
Dividend Yield
—1.89%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IOVA
51% Buy49% Sell
Avg holding period · 0 Days
OVV

No sentiment data available yet.

Top news

Latest headlines on both assets

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →

About Ovintiv Inc. (DE)

Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.

Read more on OVV →